US$ 27.99
moa of glp-1 agonists What is and Its Receptor Agonists? Mechanisms of Action and Therapeutic
Description
It is HERE

World Health Organization

GLP-1 Drugs GLP-1 Drugs GLP-1 Drugs Distribution GLP-1 Drugs Distribution Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering

A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated effectively.

The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.

It is not approved for any of these yet, but the intent is clearly broader metabolic health, not just weight loss
